# S.Lab Asia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/s-lab-asia

- Industry: Software
- Headquarters: Seoul, South Korea
- Website: www.slabhealthcare.com
- Total disclosed funding: $13M
- Latest round: Series B (Dec 28, 2021)
- Investors on record: 9

## About

Based in South Korea, S.Lab Asia inc develops advanced biopharma logistics and cold chain solutions, ensuring reliable delivery of sensitive healthcare products across various international markets.S.Lab Asia inc specializes in biopharma logistics and cold chain solutions, headquartered in Seoul, South Korea. Founded in 2014 by Dave Han, the company has completed 2 deals, with the most recent funding round being a Series B that raised KRW 15 billion on December 28, 2021. This round was led by Envisioning Partners and SKS Private Equity, and included participation from several other investors including Hyundai Motor Company and Korea Development Bank.S.Lab Asia inc focuses on advanced biopharma logistics and cold chain solutions, providing services for the reliable delivery of healthcare products, including biological specimens and vaccines. Their offerings include temperature-controlled transportation and clinical trial logistics, serving clients across South Korea, the United States, Japan, and Europe, among others. The company employs innovative tracking systems to ensure compliance and maintain product integrity during transit.S.Lab Asia inc generates revenue through B2B partnerships with pharmaceutical companies, hospitals, and research institutions, offering customized logistics solutions. Their financial agreements typically involve temperature-sensitive shipping services, reflecting the specialized nature of their offerings, which include proprietary cold chain solutions and real-time temperature logging systems.Following the Series B funding of KRW 15 billion raised in December 2021, S.Lab Asia inc aims to enhance its service offerings and expand into new markets. Plans include the development of new products aimed at improving logistics efficiency and extending geographical reach into emerging markets in Southeast Asia and Europe. The recent funding will support these initiatives, ensuring the company can meet the growing demands of its client base while maintaining compliance with industry standards.

## Funding rounds

- Series B, Dec 28, 2021, $13M — Korea Development Bank, Hana Securities, SKS, UTC Investment, Hyundai Motor Company, NICE Investment Partners, TBT Partners, K & Investment Partners, Envisioning Partners

## Investors

- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series B
- Hana Securities (https://capitalatlas.ai/funds/hana-securities) — Series B
- SKS (https://capitalatlas.ai/funds/sks) — Series B
- UTC Investment (https://capitalatlas.ai/funds/utc-investment) — Series B
- Hyundai Motor Company — Series B
- NICE Investment Partners (https://capitalatlas.ai/funds/nice-investment-partners) — Series B
- TBT Partners (https://capitalatlas.ai/funds/tbt-partners) — Series B
- K & Investment Partners (https://capitalatlas.ai/funds/k-investment-partners) — Series B
- Envisioning Partners (https://capitalatlas.ai/funds/envisioning-partners) — Series B